Optimized pipeline for personalized neurobiological insights from single patient-derived Neurospheres

被引:0
|
作者
Nugue, Guillaume [1 ]
Martins, Michele [1 ]
Vitoria, Gabriela [2 ]
Guimaraes, Beatriz Luzia De Mello Lima [2 ]
Quinones-Vega, Mauricio [1 ,3 ,4 ]
Rehen, Stevens [2 ,5 ]
Guimaraes, Marilia Z. [2 ,6 ]
Junqueira, Magno [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, BR-21941909 Rio De Janeiro, Brazil
[2] D Or Inst Res & Educ IDOR, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Inst Chem, Lab Prote LabProt, LADETEC, BR-21941598 Rio De Janeiro, Brazil
[4] Univ Fed Rio de Janeiro, Inst Biophys Carlos Chagas Filho, Precis Med Res Ctr, BR-21941902 Rio De Janeiro, Brazil
[5] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil
[6] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil
关键词
Neurosphere; TMT; IPSc; Quantitative proteomics;
D O I
10.1016/j.jprot.2024.105368
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
This pipeline presents a refined approach for deriving personalized neurobiological insights from iPSC-derived neurospheres. By employing Tandem Mass Tag (TMT) labeling, we optimized sample pooling and multiplexing for robust comparative analysis across experimental conditions, maximizing data yield per sample. Through single-patient-derived neurospheres-composed of neural progenitor cells, early neurons, and radial glia-this study explores proteomic profiling to mirror the cellular complexity of neurodevelopment more accurately than traditional 2D cultures. Given their enhanced relevance, these 3D neurospheres serve as a valuable model for elucidating neurogenesis, differentiation, and neuropathological mechanisms, contributing to the advancement of in vitro neural models and reducing dependency on animal models. Significance: This study evaluates ten protein extraction protocols using TMT 10-plex labeling to optimize proteomic analysis from single neurospheres. It compares cost, protein yield, and the ability to detect differentially expressed proteins, identifying methods like SPEED and S-Trap as efficient for high-throughput studies, while FASP excels in peptide yield. TMT labeling enhances protein identification, particularly for low-abundance proteins, and allows pre-fractionation to maximize analysis from limited samples. However, challenges such as limited PTM analysis and the potential loss of minor proteins highlight the importance of selecting protocols based on specific research goals. This work contributes to optimizing proteomic workflows for in vitro neural models, advancing single-cell analysis with minimal reliance on animal models.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] DRUG-RESPONSE ANALYSIS AND SINGLE NUCLEUS RNA SEQUENCING ON PATIENT-DERIVED NEUROSPHERES TO REVEAL DRUG RESPONSE AND RESISTANCE MECHANISMS IN GLIOBLASTOMA
    Lu, M. J. S.
    Hendriksen, J. D.
    Ariey-Bonnet, J.
    Anand, A.
    Michaelsen, S. R.
    Gonzalez, F. G. R.
    Locallo, A.
    Azam, A.
    Skjoth-Rasmussen, J.
    Hamerlik, P.
    Noroxe, D. S.
    Hasselbalch, B.
    Vik-Mo, E.
    Kristensen, B. W.
    Urup, T.
    Lassen, U.
    Poulsen, H. S.
    Wennerberg, K.
    Weischenfeldt, J.
    NEURO-ONCOLOGY, 2024, 26 : V31 - V31
  • [22] Patient-derived cell models for personalized medicine approaches in cystic fibrosis
    Ramalho, Anabela S.
    Amato, Felice
    Gentzsch, Martina
    JOURNAL OF CYSTIC FIBROSIS, 2023, 22 : S32 - S38
  • [23] Patient-derived organoids for personalized gallbladder cancer modelling and drug screening
    Yuan, Bo
    Zhao, Xiaofang
    Wang, Xiang
    Liu, Erdong
    Liu, Chunliang
    Zong, Yali
    Jiang, Youhai
    Hou, Minghui
    Chen, Yao
    Chen, Lei
    Zhang, Yongjie
    Wang, Hongyang
    Fu, Jing
    CLINICAL AND TRANSLATIONAL MEDICINE, 2022, 12 (01):
  • [24] Patient-derived tumor organoids: A preclinical platform for personalized cancer therapy
    Taurin, Sebastien
    Alzahrani, Reem
    Aloraibi, Sahar
    Ashi, Layal
    Alharmi, Rawan
    Hassani, Noora
    TRANSLATIONAL ONCOLOGY, 2025, 51
  • [25] Bladder Cancer Patient-derived Organoids and Avatars for Personalized Cancer Discovery
    Kim, Yeon Soo
    Hsieh, Andrew C.
    Lam, Hung -Ming
    EUROPEAN UROLOGY FOCUS, 2022, 8 (03): : 657 - 659
  • [26] Patient-Derived Organoids: A Game-Changer in Personalized Cancer Medicine
    Abbasian, Mohammad Hadi
    Sobhani, Navid
    Sisakht, Mahsa Mollapour
    D'Angelo, Alberto
    Sirico, Marianna
    Roudi, Raheleh
    STEM CELL REVIEWS AND REPORTS, 2025, 21 (01) : 211 - 225
  • [27] Patient-Derived Organoids of Colorectal Cancer: A Useful Tool for Personalized Medicine
    Kiwaki, Takumi
    Kataoka, Hiroaki
    JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (05):
  • [28] Redefining personalized medicine by drug response profiling of patient-derived spheroids
    Shuford, Stephen
    Wilhelm, Christine
    Smith, Ashley M.
    Rayner, Melissa
    Stuart, Jeremy
    Holmes, Lillia
    Gevaert, Matt
    Crosswell, Howland E.
    DesRochers, Teresa M.
    CANCER RESEARCH, 2019, 79 (13)
  • [29] Bladder cancer patient-derived organoids: A new frontier for personalized therapy
    Mastroianni, R.
    Frascolla, C.
    Donzelli, S.
    Pulito, C.
    Russo, A.
    Strano, S.
    Costantini, M.
    Blandino, G.
    Simone, G.
    EUROPEAN UROLOGY, 2024, 85 : S1909 - S1910
  • [30] PERSONALIZED PHARMACOGENOMICS USING GLIOMA PATIENT-DERIVED ORTHOTOPIC XENOGRAFTS (PDOXS)
    Hau, Ann-Christin
    Golebiewska, Anna
    Oudin, Anais
    Houben, Linsey
    Stieber, Daniel
    Hertel, Frank
    Niclou, Simone
    NEURO-ONCOLOGY, 2018, 20 : 281 - 281